The Farnesoid X Receptor
Top Cited Papers
Open Access
- 1 October 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (10) , 2020-2030
- https://doi.org/10.1161/01.atv.0000178994.21828.a7
Abstract
Bile acids are the end products of cholesterol metabolism. They are synthesized in the liver and secreted via bile into the intestine, where they aid in the absorption of fat-soluble vitamins and dietary fat. Subsequently, bile acids return to the liver to complete their enterohepatic circulation. The Farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily and has emerged as a key player in the control of multiple metabolic pathways. On its activation by bile acids, FXR regulates bile acid synthesis, conjugation, and transport, as well as various aspects of lipid and glucose metabolism. This review summarizes recent advances in deciphering the role of FXR in the context of hepatic lipid and glucose homeostasis and discusses the potential of FXR as a pharmacological target for therapeutic applications.Keywords
This publication has 144 references indexed in Scilit:
- Normalisation of serum cholestanol concentration in a patient with cerebrotendinous xanthomatosis by combined treatment with chenodeoxycholic acid, simvastatin and LDH apheresisNeurological Sciences, 2004
- The nuclear bile acid receptor FXR is activated by PGC-1α in a ligand-dependent mannerBiochemical Journal, 2004
- The farnesoid X receptor induces very low density lipoprotein receptor gene expressionFEBS Letters, 2004
- PGC-1α Activates CYP7A1 and Bile Acid BiosynthesisJournal of Biological Chemistry, 2003
- Targeted Deletion of the Ileal Bile Acid Transporter Eliminates Enterohepatic Cycling of Bile Acids in MiceJournal of Biological Chemistry, 2003
- Synergism between nuclear receptors bound to specific hormone response elements of the hepatic control region-1 and the proximal apolipoprotein C-II promoter mediate apolipoprotein C-II gene regulation by bile acids and retinoidsBiochemical Journal, 2003
- Natural Structural Variants of the Nuclear Receptor Farnesoid X Receptor Affect Transcriptional ActivationJournal of Biological Chemistry, 2003
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Catabolites of Cholesterol Synthesis Pathways and Forskolin as Activators of the Farnesoid X-Activated Nuclear ReceptorToxicology and Applied Pharmacology, 2000
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980